Picture of AIMS APAC REIT logo

O5RU — AIMS APAC REIT News Story

0.000.00%
sg flag iconLast trade - 00:00
FinancialsConservativeMid CapNeutral

Global Markets: Stocks set for best month ever, dollar and gold pay the price

* MSCI World Stocks index set for best month on record 
    * Europe leading with 15% surge
    * China official PMI rises to 52.1, tops forecasts
    * Dollar and gold out of favour, investors embrace risk
    * Oil and industrial commodities lifted by recovery bets
    * Sovereign bonds supported by central bank buying 
    * Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn
    * Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh

    By Marc Jones and Wayne Cole
    LONDON/SYDNEY, Nov 30 (Reuters) - World shares paused on
Monday to assess a record-breaking month as the prospect of a
vaccine-driven economic recovery next year and yet more free
money from central banks eclipsed immediate concerns about the
coronavirus pandemic.
    Neither Europe or U.S. futures made further gains, but
November's record-breaking 13% leap has added $6.7 trillion - or
$155 million a minute - to the value of world equities.  .EU 
 .N  urn:newsml:reuters.com:*:nL1N2ID0A9  urn:newsml:reuters.com:*:nL1N2IG04H 
    The rush to risk has also benefited oil, industrial
commodities and given emerging-market currencies their best time
in almost two years  EMRG/FRX , while undermining the safe-haven
dollar and gold.    
    Helping sentiment further on Monday was a survey showing
that factory activity in China beat forecasts in November, and
the country's central bank surprised with an extra helping of
cheap loans.
    Moderna provided the regular Monday dose of vaccine news,
saying it was applying for emergency-use authorization from the
U.S. Food and Drug Administration and conditional approval from
the European Union.  urn:newsml:reuters.com:*:nL1N2IG02A
    "It has been a very, very strong month for markets,
especially on the equity side but also on the fixed income side
too," said Rabobank's head of macro strategy, Elwin de Groot. 
    The positive developments on vaccines and swiftness with
which they are likely to be rolled out have been key drivers. 
    "And this market still remains very much supported by
liquidity from the central banks," De Groot said. With the
European Central Bank set to provide more stimulus next month,
"the market view seems to be, what can possibly go wrong?" 
    Many European markets are boasting their best month ever,
with France up 21% and Italy almost 26%. The MSCI measure of
world stocks  .MIWD00000PUS  is up nearly 13%, while the S&P 500
 .SPX  has climbed 11% to record highs.
    Asia-Pacific shares outside Japan  .MIAPJ0000PUS  ended 1.5%
lower on Monday but still finished the month almost 10% higher.
The Nikkei's 15% leap in Japan  .N225  was its best month since
1994.  .T 
    "Markets are overbought and at risk of a short-term pause,"
said Shane Oliver, head of investment strategy at AMP Capital.
    "However, we are now in a seasonally strong time of year and
investors are yet to fully discount the potential for a very
strong recovery next year in growth and profits as stimulus
combines with vaccines."
    Cyclical recovery shares including resources, industrials
and financials were likely to be relative outperformers, he
said.
    The surge in stocks has put competitive pressure on
safe-haven bonds, but much of that has been cushioned by
expectations of more asset buying by central banks. 
    Sweden's Riksbank unexpectedly expanded its bond purchase
program last week, and the European Central Bank is likely to
follow in December. 
    German 10-year Bund yield  DE10YT=RR  was down 1.1 basis
points at -0.6% on Monday, its lowest in three weeks. J.P.
Morgan estimates that once inflation is taken into account, 83%
of all advanced economy sovereign debt now has a negative yield.
 GVD/EUR 
   
    DOLLAR IN DECLINE
    U.S. stock futures were fractionally lower before Wall
Street's open and crucial economic indicators later this week.
 .N  
    Risk appetite was underscored, ratings and data agency S&P
Global  SPGI.N  said it was buying IHS Markit  INFO.N  for $44
billion in what will be the biggest M&A deal of 2020 so far.
 urn:newsml:reuters.com:*:nL4N2IG0BL    
    Federal Reserve Chair Jerome Powell testifies to Congress on
Tuesday amid speculation of further policy action at its next
meeting in mid-December.
    As a result, U.S. 10-year yields are ending the month almost
exactly where they started at 0.84%  US10YT=RR , a solid
performance given the exuberance in equities. 
    The U.S. dollar has not been as lucky.
    "The idea that a potential Treasury Secretary (Janet) Yellen
and Fed Chair Powell could work more closely to shape and
coordinate super-easy monetary policy and massive fiscal
stimulus that could drive a rapid post-pandemic recovery saw the
dollar under pressure," said Robert Rennie, head of financial
market strategy at Westpac.
    Against a basket of currencies, the dollar index was pinned
at 91.704  =USD  after shedding shed 2.4% for the month to lows
last seen in mid-2018.  /FRX 
    The euro has benefited from the relative outperformance of
European stocks and climbed 2.7% for the month to reach $1.1973
 EUR= . A break of the September peak at $1.2011 would open the
way to a 2018 top at $1.2555.
    The dollar has had its worst month against emerging-market
currencies in almost two years and even declined against the
Japanese yen, a safe haven of its own. It has lost 0.7% in
November to reach 103.89 yen  JPY= , though it remains well
above key support at 103.16.
    Sterling stood at $1.3326  GBP= , having climbed steadily
this month to its highest since September, as investors wagered
a Brexit deal would be brokered even as the deadline for talks
came ever closer.  urn:newsml:reuters.com:*:nL8N2IG1E3
    One major casualty of the rush to risk has been gold, which
was near a five-month trough at $1,769 an ounce  XAU= , having
shed 5.6% in November.
    Oil, in contrast, has benefited nearly 30% from the prospect
of a revival in demand should vaccines allow travel and
transport to resume next year.  O/R 
    Some profit-taking set in early on Monday ahead of an OPEC+
meeting to decide whether the producers' group will extend large
output cuts. Brent crude  LCOc1  futures fell 58 cents to
$47.60, while U.S. crude  CLc1  eased 40 cents to $45.15 a
barrel.

    <^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Asia stock markets    https://tmsnrt.rs/2zpUAr4
Asia-Pacific valuations    https://tmsnrt.rs/2Dr2BQA
Global markets have a November to remember    https://tmsnrt.rs/2VgAgCB
Emerging market stocks' November to remember    https://tmsnrt.rs/33lYqQq
World stocks set for record month    https://tmsnrt.rs/2JbbPUT
    ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>
 (Reporting by Marc Jones; editing by Ed Osmond, Larry King)
 ((marc.jones@thomsonreuters.com; +44 (0)20 7513 4042; Reuters
Messaging: marc.jones.thomsonreuters.com@reuters.net  Twitter
@marcjonesrtrs))
 
((To read Reuters Markets and Finance news, click on 
https://www.reuters.com/finance/markets
For Reuters Live Markets blog on European and UK stock markets, please click on:  LIVE/   ))

Recent news on AIMS APAC REIT

See all news